Stephen F. Carroll
Corporate Officer/Principal at Lypro Biosciences, Inc.
Profile
Stephen F.
Carroll is currently the Director of Discovery & Development at Lypro Biosciences, Inc. He previously worked as a Member at XOMA (US) LLC and as an Assistant Professor of Microbiology & Genetics at Harvard Medical School.
Stephen F. Carroll active positions
Companies | Position | Start |
---|---|---|
Lypro Biosciences, Inc.
Lypro Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lypro Biosciences Inc. operates as a therapeutic development company whose proprietary drug delivery nanotechnology increases the solubility and bioavailability of hydrophobic drugs and other therapeutic compounds and facilitates targeting to specific receptor. Its product pipeline includes therapies for infectious diseases such as aspergillosis and leishmaniasis, as well as for cancer such as mantle cell lymphoma. The company was founded by Michael Oda, Murray P Brozinsky and Robert O. Ryan in 2004 and is headquartered in Berkeley, CA. | Corporate Officer/Principal | - |
Former positions of Stephen F. Carroll
Companies | Position | End |
---|---|---|
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology XOMA (US) LLC develops pharmaceutical preparations. It offers proprietary drugs and toiletries. The company is headquartered in Emeryville, CA. | Corporate Officer/Principal | - |
Harvard Medical School | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Lypro Biosciences, Inc.
Lypro Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lypro Biosciences Inc. operates as a therapeutic development company whose proprietary drug delivery nanotechnology increases the solubility and bioavailability of hydrophobic drugs and other therapeutic compounds and facilitates targeting to specific receptor. Its product pipeline includes therapies for infectious diseases such as aspergillosis and leishmaniasis, as well as for cancer such as mantle cell lymphoma. The company was founded by Michael Oda, Murray P Brozinsky and Robert O. Ryan in 2004 and is headquartered in Berkeley, CA. | Health Technology |
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology XOMA (US) LLC develops pharmaceutical preparations. It offers proprietary drugs and toiletries. The company is headquartered in Emeryville, CA. | Health Technology |
- Stock Market
- Insiders
- Stephen F. Carroll